Literature DB >> 16282174

Glioblastoma multiforme and the epidermal growth factor receptor.

Henry S Friedman1, Darell D Bigner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282174     DOI: 10.1056/NEJMp058186

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  20 in total

1.  Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells.

Authors:  Yu Zhou; Daryl C Drummond; Hao Zou; Mark E Hayes; Gregory P Adams; Dmitri B Kirpotin; James D Marks
Journal:  J Mol Biol       Date:  2007-05-10       Impact factor: 5.469

2.  Harmine hydrochloride inhibits Akt phosphorylation and depletes the pool of cancer stem-like cells of glioblastoma.

Authors:  Huailei Liu; Dayong Han; Yaohua Liu; Xu Hou; Jianing Wu; Huadong Li; Jie Yang; Chen Shen; Guang Yang; Changyu Fu; Xianfeng Li; Hui Che; Jing Ai; Shiguang Zhao
Journal:  J Neurooncol       Date:  2013-02-08       Impact factor: 4.130

3.  A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas.

Authors:  Vasilios Karavasilis; Vassiliki Kotoula; George Pentheroudakis; Despina Televantou; Sofia Lambaki; Sofia Chrisafi; Mattheos Bobos; George Fountzilas
Journal:  J Neurol       Date:  2013-01-05       Impact factor: 4.849

4.  Probing into the biological processes influenced by ESC factor and oncoprotein HMGA2 using iPSCs.

Authors:  Amir Morshedi; Zhonglu Ren; Jinming Li; Peter Dröge
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

5.  EGFR and EGFRvIII interact with PUMA to inhibit mitochondrial translocalization of PUMA and PUMA-mediated apoptosis independent of EGFR kinase activity.

Authors:  Hu Zhu; Xinyu Cao; Francis Ali-Osman; Stephen Keir; Hui-Wen Lo
Journal:  Cancer Lett       Date:  2010-02-13       Impact factor: 8.679

6.  Epithelial Growth Factor Receptor Inhibitors for treatment of recurrent or progressive high grade glioma: an exploratory study.

Authors:  M Preusser; E Gelpi; A Rottenfusser; K Dieckmann; G Widhalm; W Dietrich; A Bertalanffy; D Prayer; J A Hainfellner; Christine Marosi
Journal:  J Neurooncol       Date:  2008-05-06       Impact factor: 4.130

Review 7.  STAT3 regulation of glioblastoma pathogenesis.

Authors:  Núria de la Iglesia; Sidharth V Puram; Azad Bonni
Journal:  Curr Mol Med       Date:  2009-06       Impact factor: 2.222

8.  Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators.

Authors:  Hui-Wen Lo; Xinyu Cao; Hu Zhu; Francis Ali-Osman
Journal:  Clin Cancer Res       Date:  2008-10-01       Impact factor: 12.531

9.  microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma.

Authors:  Jungeun Kim; Ying Zhang; Michael Skalski; Josie Hayes; Benjamin Kefas; David Schiff; Benjamin Purow; Sarah Parsons; Sean Lawler; Roger Abounader
Journal:  Cancer Res       Date:  2014-01-14       Impact factor: 12.701

10.  Functional delivery of siRNA in mice using dendriworms.

Authors:  Amit Agrawal; Dal-Hee Min; Neetu Singh; Haihao Zhu; Alona Birjiniuk; Geoffrey von Maltzahn; Todd J Harris; Deyin Xing; Stephen D Woolfenden; Phillip A Sharp; Alain Charest; Sangeeta Bhatia
Journal:  ACS Nano       Date:  2009-09-22       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.